Balancing effectiveness, toxicity, and individualization: enfortumab vedotin in advanced urothelial cancer
@article{TAU136301,
author = {Nuowei Wang and Karl H. Tully},
title = {Balancing effectiveness, toxicity, and individualization: enfortumab vedotin in advanced urothelial cancer},
journal = {Translational Andrology and Urology},
volume = {14},
number = {3},
year = {2025},
keywords = {},
abstract = {},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/136301}
}